Dhanuka Agritech Ltd

📈 Dhanuka Agritech Q4 FY26 Results: Revenue Up 9%, PAT at ₹97.77 Cr | Key Insights

- Revenue from operations: ₹483.34 Cr in Q4 FY26 (+9% vs ₹442.02 Cr in Q4 FY25)

- Profit after tax: ₹97.77 Cr in Q4 FY26 (vs ₹75.50 Cr in Q4 FY25)

- EBITDA: ₹124.89 Cr in Q4 FY26 (up from ₹109.75 Cr in Q4 FY25)

- Zone-wise revenue contribution: North (32%), South (33%), West (23%), East (12%)

- Product mix: Insecticides (41%), Herbicides (31%), Fungicides (14%), Others (14%)

- Dahej plant sales: ₹50 Cr in FY26 (₹13 Cr loss); FY27 target ₹75 Cr

- Acquired Triadimenol & Iprovalicarb from Bayer; shifting formulation to India

- Biological products revenue fell to ₹70 Cr in FY26 (from ₹110 Cr in FY25) due to regulations

- Raw material inflation: 5-7%, partially passed to customers

- Herbicide demand rising due to labor shortages

- Board approved ₹70 Cr share buyback (₹1,400/share) & 100% dividend (₹2/share)

- ESOP scheme introduced for leadership development